BioPharma Credit provides investors with an opportunity to gain exposure to the fast-growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. Its primary objective is to generate predictable income for shareholders over the long term.
B&C came up with a dynamic design for the annual report to emphasise the company’s market-leading position, established track record, size and consistent performance - with authenticity. The use of striking imagery to help investors visualise the more technical elements of the company’s investments, alongside clean typography, and considered use of colours white space, all help convey the company's professionalism and reinforce its emphasis on sustainable investing and its credibility in the life sciences debt space.
The layout presents clear sectioning for easy navigation, helping to guide the reader from an initial overview of its strategy through its market and portfolio review, investment managers' report, asset performance, its approach to stakeholder engagement, risk, ESG and governance, and finally onto its detailed financial statements.
